...
首页> 外文期刊>African journal of medicine and medical sciences. >Comparative evaluation of hypofractionated radiotherapy and conventional fractionated radiotherapy in the management of carcinoma of the cervix in Ibadan, Nigeria.
【24h】

Comparative evaluation of hypofractionated radiotherapy and conventional fractionated radiotherapy in the management of carcinoma of the cervix in Ibadan, Nigeria.

机译:在尼日利亚伊巴丹进行子宫颈癌分次放疗和常规分次放疗的比较评价。

获取原文
获取原文并翻译 | 示例

摘要

Four hundred and eighty patients with histologically confirmed carcinoma of the uterine cervix were randomized into 2 groups to either receive hypofractionated radiotherapy (HF--230 patients--study group) or conventional fractionated radiotherapy (CFR--250 patients--control group) between December 1988 and November 1992 at the Radiotherapy Department, University College Hospital, Ibadan. The 5-year survival rate for HF patients in Stages I, II, III and IV were, respectively, 91.3%, 67.2%, 40.2% and 18.0% while for CFR patients in Stages I, II, III and IV were respectively, 92.8%, 69.2%, 42.5% and 19.6%. Though early radiation adverse effects were similar in CFR and HF patients, marked late adverse radiation effects were observed in HF patients than in CFR patients. Complete response rate and local tumour controls were found to be similar in the HF and CFR patients. This study revealed that with similar 5-year survival, complete response rate and local tumour control in HF and CFR patients while a significantly higher late radiation adverse effects were recorded in HF patients, conventional fractionated radiotherapy is the preferred form of radiation therapy in the management of carcinoma of the uterine cervix. Administration of hypofractionated radiotherapy for cervical cancer patients with the aim of maximizing the use of few available radiotherapy facilities, as currently obtained in some radiotherapy centres in Nigeria will result in high post treatment morbidity.
机译:480例经组织学证实为子宫颈癌的患者被随机分为两组,分别接受低分割放疗(HF--230患者-研究组)或常规分段放疗(CFR--250患者-对照组) 1988年12月和1992年11月在伊巴丹大学附属医院放疗科。 I,II,III和IV期HF患者的5年生存率分别为91.3%,67.2%,40.2%和18.0%,而CFR患者在I,II,III和IV期分别为92.8% %,69.2%,42.5%和19.6%。尽管CFR和HF患者的早期放射不良反应相似,但HF患者比CFR患者观察到明显的晚期放射不良反应。在HF和CFR患者中发现完全缓解率和局部肿瘤对照相似。这项研究表明,HF和CFR患者具有相似的5年生存率,完全缓解率和局部肿瘤控制,而HF患者的晚期放射不良反应明显更高,因此常规分次放疗是治疗中首选的放射治疗形式子宫颈癌。如目前在尼日利亚一些放射治疗中心所获得的那样,对子宫颈癌患者进行次分割放射治疗的目的是最大程度地利用少数可用的放射治疗设施,这将导致较高的治疗后发病率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号